Our study aims to identify novel therapeutic targets that can improve the prognosis for HCC patients by investigating the expression and functional dynamics of SLC2A2 in correlation with liver differentiation markers [29,30]. This evidence concerns the gene SLC2A2 and hepatocellular carcinoma.